Growth Metrics

Recursion Pharmaceuticals (RXRX) Receivables - Net (2020 - 2022)

Recursion Pharmaceuticals posted quarterly Receivables - Net of $21000.0 for Q2 2022, down 57.14% year-on-year from $49000.0 in Q2 2021, and down 38.24% on a QoQ basis from $34000.0 in Q1 2022.

Recursion Pharmaceuticals (RXRX) has 3 years of Receivables - Net data on file, last reported at $21000.0 in Q2 2022.

  • For the quarter ending Q2 2022, Receivables - Net fell 57.14% year-over-year to $21000.0; the trailing twelve-month figure through Jun 2022 stood at $21000.0 (down 57.14% YoY), and the FY2021 full-year result was $34000.0, down 78.21% from the prior year.
  • Receivables - Net for Q2 2022 stood at $21000.0, down from $34000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $156000.0 in Q4 2020 and bottomed at $21000.0 in Q2 2022.
  • The 3-year median for Receivables - Net is $34000.0 (2021), against an average of $57000.0.
  • The widest annual swing landed in 2021, when Receivables - Net slumped 78.21%; it then tumbled 52.11% in 2022.
  • A 3-year view of Receivables - Net shows it stood at $156000.0 in 2020, then plunged by 78.21% to $34000.0 in 2021, then sank by 38.24% to $21000.0 in 2022.
  • The last three Receivables - Net figures came in at $21000.0 (Q2 2022), $34000.0 (Q1 2022), and $34000.0 (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Recursion Pharmaceuticals 1.90 Bn 1.24 Bn -6.02 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2022 21,000.00
Jun 30, 2022 21,000.00
Mar 31, 2022 34,000.00
Mar 31, 2022 34,000.00
Dec 31, 2021 34,000.00
Dec 31, 2021 34,000.00
Sep 30, 2021 34,000.00
Sep 30, 2021 34,000.00
Jun 30, 2021 49,000.00
Jun 30, 2021 49,000.00
Mar 31, 2021 71,000.00
Mar 31, 2021 71,000.00
Dec 31, 2020 156,000.00
Dec 31, 2020 156,000.00